Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the Uni…
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Moderna, Inc. (MRNA) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 37,172.73 | 13,356.09 | 617.98 | 158.27 | -1,101.60 | 0.00 | 12.1662 | 43.61 | -0.8194 | -20.1809 | -0.08 | -0.09 | 6.8862 | - - | ||
| Maximum | - - | - - | - - | 1,535,067.00 | 609,984.00 | 35,800.00 | 99,050.00 | 5,421.00 | 0.02 | 701.8537 | 2,849.43 | 3.0051 | 85.3485 | 0.15 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -164.8536 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0844 | - - | ||
| Vertex Pharmaceuticals Incorporated VRTX | 452.55 | 2.18 0.48% | 135 vs. 1,124 | 116,544.00 | 2,687.00 | 1,099.00 | 1,058.00 | 11,242.00 | 4.2600 | 24.6835 | 0.0000 | 0.8725 | 0.4092 | 0.0593 | 0.0460 | 3.1520 | 257.00 | ||
| Beam Therapeutics Inc. BEAM | 23.52 | -0.06 -0.25% | 60 vs. 968 | 1,947.00 | 7.00 | -98.00 | -102.00 | -1,288.00 | -1.2100 | -6.7607 | 0.0000 | 0.2671 | -13.3157 | -0.1080 | -0.0726 | 5.8464 | 82.00 | ||
| Krystal Biotech, Inc. KRYS | 186.20 | 3.91 2.14% | 13 vs. 226 | 5,355.00 | 45.00 | 0.00 | 14.00 | -268.00 | 0.0300 | 1336.3467 | 0.0000 | 0.9465 | 0.0206 | 0.0012 | 0.0011 | 12.2870 | 28.00 | ||
| Intellia Therapeutics, Inc. NTLA | 13.99 | 0.19 1.38% | 263 vs. 2,217 | 1,424.00 | 28.00 | -107.00 | -123.00 | -1,765.00 | -1.1200 | -6.0491 | 0.0000 | 0.9132 | -3.7130 | -0.1037 | -0.0853 | 8.4537 | 101.00 | ||
| Moderna, Inc. MRNA | 39.96 | 1.71 4.47% | 1,598 vs. 6,547 | 15,377.00 | 167.00 | -1,175.00 | -1,185.00 | 12,431.00 | -3.0800 | -8.5828 | 0.0000 | 0.2096 | -7.0359 | -0.0917 | -0.0702 | 3.7508 | 384.00 | ||
| Reata Pharmaceuticals, Inc. RETA | 172.36 | 0.04 0.02% | 1,909 vs. 954 | 6,566.00 | 22.00 | 192.00 | -70.00 | -1,490.00 | 5.1200 | 5.4820 | 0.0000 | 0.9628 | 8.4849 | 2.2110 | 0.3840 | 2.8209 | 38.00 | ||
| CureVac N.V. CVAC | 2.58 | 0.02 0.78% | 57 vs. 471 | 578.00 | 12.00 | -70.00 | -101.00 | -1,636.00 | -0.3100 | -2.2038 | 0.0000 | -2.3694 | -5.7022 | -0.1579 | -0.1022 | 2.0371 | 224.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.